Trial record 1 of 1 for: R668-AD-0914
Previous Study | Return to List | Next Study
Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic Dermatitis
This study has been completed.
First Posted: December 14, 2010
Last Update Posted: October 4, 2012
Information provided by (Responsible Party):